产品名称 | NebuSelect™ Recombinant Mouse SLAMF7/CRACC/CD319, His-tag |
---|---|
目录号 | NBL-242082 |
别名 | SLAMF7/CRACC/CD319; CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12 |
外观 | see COA |
分子量 | Ser23-Gly224 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8BHK6-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242082-100ug | 100ug | Inquire | Inquire | |
NBL-242082-1mg | 1mg | Inquire | Inquire | |
NBL-242082-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse SLAMF7/CRACC/CD319, His-tag
Catalog#:
NBL-242082
Description:
NebuSelect™ Recombinant Mouse SLAMF7/CRACC/CD319, His-tag(Cat#NBL-242082) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser23-Gly224.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 23.1 kDa. Due to glycosylation, the protein migrates to 30-50 kDa based on Bis-Tris PAGE result.
Target Name:
SLAMF7/CRACC/CD319; CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12
Target Information:
CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
Amino Acid Sequence:
Ser23-Gly224
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.